BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 9358550)

  • 1. The stability of insulin in crystalline and amorphous solids: observation of greater stability for the amorphous form.
    Pikal MJ; Rigsbee DR
    Pharm Res; 1997 Oct; 14(10):1379-87. PubMed ID: 9358550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid-state stability of human insulin. I. Mechanism and the effect of water on the kinetics of degradation in lyophiles from pH 2-5 solutions.
    Strickley RG; Anderson BD
    Pharm Res; 1996 Aug; 13(8):1142-53. PubMed ID: 8865303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid-state stability of human insulin. II. Effect of water on reactive intermediate partitioning in lyophiles from pH 2-5 solutions: stabilization against covalent dimer formation.
    Strickley RG; Anderson BD
    J Pharm Sci; 1997 Jun; 86(6):645-53. PubMed ID: 9188045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.
    Lin SY; Lin HL; Chi YT; Huang YT; Kao CY; Hsieh WH
    Int J Pharm; 2015 Dec; 496(2):457-65. PubMed ID: 26481469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
    Parikh T; Sandhu HK; Talele TT; Serajuddin AT
    Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of annealing on the stability of amorphous solids: chemical stability of freeze-dried moxalactam.
    Abdul-Fattah AM; Dellerman KM; Bogner RH; Pikal MJ
    J Pharm Sci; 2007 May; 96(5):1237-50. PubMed ID: 17455341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the solid-state properties of crystalline lysozyme during pharmaceutical unit-operations.
    Mohammad MA; Grimsey IM; Forbes RT
    J Pharm Biomed Anal; 2015 Oct; 114():176-83. PubMed ID: 26068908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Stabilization of Amorphous Zopiclone in an Amorphous Solid Dispersion.
    Milne M; Liebenberg W; Aucamp M
    AAPS PharmSciTech; 2015 Oct; 16(5):1190-202. PubMed ID: 25732372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sucrose and mannitol on asparagine deamidation rates of model peptides in solution and in the solid state.
    Li B; O'Meara MH; Lubach JW; Schowen RL; Topp EM; Munson EJ; Borchardt RT
    J Pharm Sci; 2005 Aug; 94(8):1723-35. PubMed ID: 15986465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
    McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
    Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vacuum drying on protein-mannitol interactions: the physical state of mannitol and protein structure in the dried state.
    Sharma VK; Kalonia DS
    AAPS PharmSciTech; 2004 Feb; 5(1):E10. PubMed ID: 15198531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sodium tetraborate and boric acid on nonisothermal mannitol crystallization in frozen solutions and freeze-dried solids.
    Izutsu K; Ocheda SO; Aoyagi N; Kojima S
    Int J Pharm; 2004 Apr; 273(1-2):85-93. PubMed ID: 15010133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the physical stability of freeze-dried amorphous sugar matrices by compression at several hundreds MPa.
    Kagotani R; Kinugawa K; Nomura M; Imanaka H; Ishida N; Imamura K
    J Pharm Sci; 2013 Jul; 102(7):2187-97. PubMed ID: 23625861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quantitative assessment of the significance of molecular mobility as a determinant for the stability of lyophilized insulin formulations.
    Yoshioka S; Aso Y
    Pharm Res; 2005 Aug; 22(8):1358-64. PubMed ID: 16078146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance comparison between crystalline and co-amorphous salts of indomethacin-lysine.
    Kasten G; Nouri K; Grohganz H; Rades T; Löbmann K
    Int J Pharm; 2017 Nov; 533(1):138-144. PubMed ID: 28947246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of types of sugar on the stabilization of protein in the dried state.
    Imamura K; Ogawa T; Sakiyama T; Nakanishi K
    J Pharm Sci; 2003 Feb; 92(2):266-74. PubMed ID: 12532376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porosity and water activity effects on stability of crystalline β-carotene in freeze-dried solids.
    Harnkarnsujarit N; Charoenrein S; Roos YH
    J Food Sci; 2012 Nov; 77(11):E313-20. PubMed ID: 23094980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability II: stability of a vaccine.
    Abdul-Fattah AM; Truong-Le V; Yee L; Pan E; Ao Y; Kalonia DS; Pikal MJ
    Pharm Res; 2007 Apr; 24(4):715-27. PubMed ID: 17372697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.